Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor α and melphalan on the human fibrinolytic system

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3948-3953

  Zwaveling, Jan H ^a   Maring, John K ^a   Mulder, André B ^a   Bom, Victor J J ^a   Van Ginkel, Robert J ^a   Koops, Heimen Schraffordt ^a   Girbes, Armand R J ^a   Hoekstra, Harald J ^a   Van Der Meer, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HYPERTHERMIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; LIMB PERFUSION; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; EXTREMITIES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; HYPERTHERMIA, INDUCED; INTERFERON-GAMMA, RECOMBINANT; MELPHALAN; NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029794310     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hoekstra, H J., Schraffordt Koops, H., Molenaar, W M , and Oldhoff, J. Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities. Cancer (Phila.), 60: 1703-1707, 1987.
2. Lejeune, F L., Lienard, D , and El Douaihy, M. Results of 206 isolated limb perfusions for malignant melanoma. Eur. J. Surg. Oncol., 15: 510-519, 1989.
3. Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N., and Lejeune, F High-dose recombinant tumor necrosis factor a in combination with interferon γ and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol., 10: 52-60, 1992
4. Eggermont, A. M. M , Schraffordt Koops, H., Lienard, D , Kroon, B. B. R., van Geel, A. N , Hoekstra, H. J , and Lejeune, F. J. Isolated limb perfusion with high dose tumor necrosis factor-γ in combination with interferon-y and melphalan for irresectable extremity soft tissue sarcomas: a multicenter trial. J. Clin. Oncol , in press, 1996
5. Fraker, D. L., Alexander, H. R., Andrich, M., and Rosenberg, S. A. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon γ. results of a tumor necrosis factor dose-escalation study. J. Clin Oncol., 14: 479-489, 1996.
6. Aggarwal, B. B., Eessalu, T E., and Mass, P. E. Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon. Nature (Lond.), 318: 665-667, 1985.
7. Ruggiero, V , Tavernier, J., Fiers, W., and Bagliont, C. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J. Immunol , 136: 2445-2450, 1986
8. Fiers, W., Brouckaert, P., and Guisez, Y. Recombinant interferon γ and its synergism with tumor necrosis factor in the human and mouse systems. In. H. Schellekens and W. E. Stewart (eds), The Biology of the Interferon System, pp. 241-248 Amsterdam, Elsevier Science, 1986.
9. Sohmura, Y Antitumor effect of recombinant human tumor necrosis factor a and its augmentation in vitro and m vivo. In: B. Bonavida, G. E. Gifford, H Kirchner, and L. J. Old (eds): Tumor Necrosis Factor/Cachectin and Related Cytokines, pp 189-195 Basel, S. Karger AG, 1988.
10. Soehnlen, B., Liu, R., and Salmon, S. Recombinant TNF exhibits antitumor activity against clonogemc human tumor cells and synergism with gamma interferon Proc. Am Assoc. Cancer Res , 26: 303, 1985.
11. Zwaveling, J. H., Maring, J. K., Clarke, F L., van Ginkel, R. J., Limburg, P. C., Hoekstra, H. J., Schraffordt Koops, H., and Girbes, A. R. J. High plasma levels of TNF-α and short-lived sepsis syndrome in patients undergoing hypertermic isolated limb perfusion with recombinant TNF-α, interferon γ and melphalan. Crit. Care Med , 24: 765-770, 1996
12. Eggimann, P , Chioléro, R., Chassot, P. G., Lienard, D., Gerain, J., and Lejeune, F. Systemic and hernodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest, 107: 1074-1082, 1995
13. Hoekstra, H. J., Naujocks, T , Schraffordt Koops, H., Beekhuis, H , van Groningen, A , Stuling, R., ter Veen, H., and Oldhoff, J. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results. Reg. Cancer Treat., 4: 301-304, 1992.
14. Sorkin, P , Abu-Abid, S., Lev, D , Gutman, M , Aderka, D., Halpern, P , Setton, A , Kudlik, N., Bar-On, J , Rudich, V , Meiler, I , and Klausner, J. M. Systemic leakage and side effects of tumor necrosis factor a administered via isolated limb perfusion can be manipulated by flow rate adjustment Arch Surg., 130: 1079-1084, 1995
15. Thijs, L. G., de Boer, J P., de Groot, M C. M., and Hack, C. E. Coagulation disorders in septic shock. Int Care Med., 19 S8-S15, 1993
16. Creech, O., and Krementz, E. T Cancer chemotherapy by perfusion. Adv. Cancer Res , 6: 111-147, 1968.
17. Rock, C. S , and Lowry, S F Current research review. Tumor necrosis factor α. J. Surg. Res., 51: 434-445, 1991.
18. Dofferhof, A S M., Vellenga, E , Limburg, P C., van Zanten, A., Mulder, P. O M., and Weits, J. Tumour necrosis factor (cachexin) and other cytokines in septic shock a review of the literature. Neth J Med, 39 45-62, 1991
19. Schutze, S., Machleidt, T., and Kronke, M Mechanisms of tumor necrosis factor action Semm. Oncol., 2: 16-24, 1992.
20. Beutler, B , and Cerami, A Caohectm: more than a tumor necrosis factor N. Engl. J Med., 316: 379-385, 1987
21. Hesse, D. G , Tracey, K. J., Fong, Y , Manogue, K. R., Palladino, M. A , Cerami, A , and Shires, G. T. Cytokme appearance in human endotoxemia and primate bacteremia Surg Gynecol. & Obstet , 166: 147-153, 1988
22. Cannon, J G , Tompkins, R. G , Gelfand, J A., Michie, H. R., Stanford, G. G., van der Meer, J W. M., Endres, S., Lonneman, G., Corsetti, J., Chemow, B., Wilmore, D. W., Wolff, S M., Burke, J. F., and Dinarello, C A. Circulating interleukin-1 and tumor necrosis factor m septic shock and experimental endotoxin fever. J. Infect. Dis , 161: 79-84, 1990.
23. Glauser, M. P., Zanetti, G., Baumgartner, J D., and Cohen, J. Septic shock: pathogenesis Lancet, 338: 732-735, 1991.
24. Silverman, P., Goldsmith, G H , Spitzer, T. R., Rehmus, E. H , and Berger, N A Effect of tumor necrosis factor on the human fibrinolytic system. J Clin Oncol., 469: 468-475, 1990
25. van der Poll, T., Levi, M., Buller, H. R , van Deventer, S. J. H , de Boer, J. P , Hack. C. E , and ten Cate, J. W. Fibrinolytic response to tumor necrosis factor in healthy subjects J. Exp Med., 174: 729-732, 1991.
26. Philippe, J., Offner, F., Declerk, P. J., Lerouw-Roels, G , Vogelaers, D., Baele, G , and Collen, D. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb. Haemostasis, 65: 291-295, 1991
27. Bone, R C. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch. Intern Med., 152: 1381-1389, 1992
28. Lorente, I. A., Garcia-Frade, L. J., Landin, L , de Pablo, R , Torrado, C., Renes, E , and Garcia-Avello, A. Time course of hemostatic abnormalities in sepsis and it relation to outcome Chest, 103: 1536-1542, 1993.
29. Levi, M., ten Cate, H., van der Poll, T , and van Deventer, S J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA, 270: 975-979, 1993.
30. Roman, J., Velasco, F., Fernandez, F., Fernandez, M., Villalba, R , Rubio, V., Vicente, A., and Torres, A. Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock. Haemostasis, 23: 142-148, 1993.
31. Fourrier, F , Chopin, C., Goudemand, J., Hendrycx, S., Caron, C , Rime, A , Marey, A., and Lestavel, P. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest, 101: 816-823, 1992.
32. van Hinsbergh, V W. M , Bauer, K. A., Kooistra, T., Kluft, C., Dooijewaard, G., Sherman, M L, and Nieuwenhuizen, W. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase m tissue-type plasminogen activator. plasminogen activator inhibitor type-1 and fibrin(ogen) degradation products Blood, 76: 2284-2289, 1990.
33. Levi, M., ten Cate, H., Bauer, K. A., van der Poll, T., Edgington, T. S., Buller, H R., van Deventer, S. J H., Hack, C E , ten Cate, J. W , and Rosenberg, R. D. Inhibition of endotoxin-mduced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees J Clin. Invest., 93: 114-120, 1994
34. Schleef, R. R., Bevilacqua, M. P., Sawdey, M., Gimbrone, M. A., and Loskutoff, D. J. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type I plasminogen activator inhibitor J Biol Chem., 263: 5797-5803, 1988
35. van Hinsbergh, V W , M., Kooistra, T , van den Berg, E. A., Princen, H. M. G., Fiers, W , and Emeis, J. J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood, 72 1467-1473, 1988.
36. Emeis, J. J , Hoekzema, R., and de Vos, A F. Inhibiting interleukin-1 and tumor necrosis factor-α docs not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo Blood, 85: 115-120, 1995
37. Baars, J W , de Boer, J. P., Wagstaff, J , Roem, D., Eerenberg-Belmer, A. J. M., Nauta, J , Pinedo, H M., and Hack, C. E. Interleukin-2 induces activation of coagulation and fibrinolysis; resemblance to the changes seen during experimental endotoxaemia. Br. J Haematol, 82: 295-301, 1992.
38. van der Poll, T., Büller, H. R , ten Cate, H., Wortel, C. H., Bauer, K. A , van Deventer, S. J. H., Hack, C E., Sauerwein, H. P., Rosenberg, R. D., and ten Cate, J W. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N. Engl. J Med., 322: 1622-1627, 1990.
39. Old, L J. General discussion II. In. L. S Old (ed.), Ciba Foundation Symposium 131: Tumor Necrosis Factor and Related Cytokines, pp. 185-191 New York, John Wiley & Sons, 1987.